Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Transplantation and Cellular Therapy|February 16, 2023
Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood TransplantationSho Shibata, Yasuyuki Arai, Tadakazu Kondo, et al.
Blood Advances|January 20, 2023
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemiaYu Akahoshi, Hideki Nakasone, Katsuto Takenaka, et al.
Bone Marrow Transplantation|August 16, 2018
Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decadesMasamitsu Yanada, Masayoshi Masuko, Jinichi Mori, et al.
International Journal of Hematology|October 14, 2017
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in JapanTatsunori Goto, Takashi Tanaka, Masashi Sawa, et al.
International Journal of Hematology|July 2, 2013
A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study GroupYoshihiro Torimoto, Kazuya Sato, Katsuya Ikuta, et al.
Oncotarget|November 10, 2018
Clinical impact of serum soluble SLAMF7 in multiple myelomaMariko Ishibashi, Saori Soeda, Makoto Sasaki, et al.
Annals of Hematology|July 1, 2016
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' eraYutaka Tsukune, Makoto Sasaki, Takeshi Odajima, et al.
Molecular Cancer Research : MCR|January 25, 2020
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple MyelomaMariko Ishibashi, Risa Takahashi, Asako Tsubota, et al.
Transplantation and Cellular Therapy|December 26, 2021
Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell TransplantationKotaro Miyao, Yachiyo Kuwatsuka, Makoto Murata, et al.
International Journal of Hematology|July 30, 2021
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapyShinichi Kako, Fumihiko Hayakawa, Kiyotoshi Imai, et al.
Pageof 27